CytRx Corp (CYTR) Posts Q2 GAAP Loss of 63c/Share

CytRx Corp (NASDAQ: CYTR) reported Q2 GAAP loss of $0.63 per share, which may not compare wtih the analyst estimate of ($0.30).

For earnings history and earnings-related data on CytRx Corp (CYTR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
• Allarity reports Q2 2026 results, completes stenoparib manufacturing